CIK: 0001538653 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $1,500,159 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CACC | CREDIT ACCEP CORP MICH | 1,552,428 | $688,378 | 45.9% | $107.75 | +356.0% | COM | 225310101 |
| CMPR | CIMPRESS PLC | 3,906,492 | $320,020 | 21.3% | $129.96 | -31.8% | SHS EURO | G2143T103 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $240,384 | 16.0% | $81.92 | +47.0% | COM | 981419104 |
| W | WAYFAIR INC | 3,752,264 | $210,802 | 14.1% | $53.95 | -10.7% | CL A | 94419L101 |
| YELP | YELP INC | 796,371 | $27,937 | 1.9% | $30.67 | +13.9% | CL A | 985817105 |
| BTI | BRITISH AMERN TOB PLC | 220,100 | $8,051 | 0.5% | $31.45 | — | SPONSORED ADR | 110448107 |
| PM | PHILIP MORRIS INTL INC | 28,000 | $3,399 | 0.2% | $91.29 | +20.3% | COM | 718172109 |
| POWW | AMMO INC | 587,000 | $839 | 0.1% | $2.31 | -31.5% | COM | 00175J107 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 386,000 | $349 | 0.0% | $1.03 | -10.1% | COM | 53566P109 |